Pages that link to "Q80203392"

The following pages link to Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia (Q80203392):

Displaying 24 items.

• FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013? (Q27028163) (← links)
• Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study (Q27851545) (← links)
• Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia (Q33555627) (← links)
• Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report (Q35215042) (← links)
• Interactive diagnostics in the indication to allogeneic SCT in AML. (Q37442649) (← links)
• Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. (Q37514846) (← links)
• Allogeneic stem cell transplantation in acute myeloid leukemia: establishment of indications on the basis of individual risk stratification (Q37559330) (← links)
• Older patients with acute myeloid leukemia (Q37810969) (← links)
• Therapeutic Advances in Acute Myeloid Leukemia (Q37827282) (← links)
• Acute myeloid leukaemia in the elderly: a review (Q37840260) (← links)
• Acute myeloid leukemia in older adults (Q38026008) (← links)
• Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients (Q38213704) (← links)
• Acute myeloid leukemia and myelodysplastic syndromes in older adults (Q38234863) (← links)
• Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly (Q38651372) (← links)
• Acute Myeloid Leukemia in the Elderly Patient: New Strategies (Q38835119) (← links)
• Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial. (Q39808782) (← links)
• TP53 mutations in older adults with acute myeloid leukemia. (Q40967841) (← links)
• Administration Schedule of Daunorubicin for Elderly Patients with Acute Myelogenous Leukemia: A Single-institute Experience (Q51048055) (← links)
• Influence of IDH on FLT3-ITD status in newly diagnosed AML. (Q54990383) (← links)
• The prognostic relevance of flt3 and npm1 mutations on older patients treated intensively or non-intensively: a study of 1312 patients in the UK NCRI AML16 trial (Q87366126) (← links)
• [Comparison of efficacy and prognostic factors in elderly acute myelogenous patients with MA or CAG induction chemotherapy regimen] (Q89097361) (← links)
• Outcomes of Older Patients with NPM1 Mutated and FLT3-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation (Q89770395) (← links)
• The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting (Q90592722) (← links)
• Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemia (Q92023436) (← links)